Results From LUMMICAR-2: A Phase 1b/2 Study of Fully Human B-Cell Maturation Antigen-Specific CAR T Cells (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma

Kumar, SK; Baz, RC; Orlowski, RZ; Anderson, LD; Ma, H; Shrewsbury, A; Croghan, KA; Bilgi, M; Kansagra, A; Kapoor, P; Li, ZH; Brayer, J

Kumar, SK (corresponding author), Mayo Clin Rochester, Div Hematol, Rochester, MN 55904 USA.

CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021; 19 (3): 18

Abstract

A SUMMARY One-Year Follow-Up of ZUMA- 2, the Multicenter, Registrational Study of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma KT......

Full Text Link